Literature DB >> 6109908

Anticoagulants in coronary heart disease--retrospect and prospect.

J R Mitchell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109908     DOI: 10.1016/s0140-6736(81)92095-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Therapeutic ranges in anticoagulant administration.

Authors:  L Poller
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

2.  Secondary prevention of myocardial infarction: an uncertain feeling.

Authors:  J T Hart; S L Barley
Journal:  J R Coll Gen Pract       Date:  1982-11

Review 3.  "But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

Review 4.  Timolol after myocardial infarction: an answer or a new set of questions?

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

5.  Medical management of acute myocardial infarction in Ireland: information from the Second International Study of Infarct Survival (ISIS-2).

Authors:  G A MacGowan; D O'Callaghan; J H Horgan
Journal:  Ir J Med Sci       Date:  1991-11       Impact factor: 1.568

6.  Indications for oral anticoagulant treatment.

Authors:  A S Gallus
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

7.  Oral anticoagulant in patients surviving myocardial infarction. A new approach to old data.

Authors:  A Leizorovicz; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Therapeutic control of anticoagulant treatment.

Authors:  B M Duxbury
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

9.  Oral anticoagulants reassessed.

Authors:  L Poller
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

Review 10.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.